NantHealth Revenue, Profits - NH Quarterly Income Statement

Add to My Stocks
$3.03 $0.09 (2.88%) NH stock closing price Mar 20, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking NantHealth stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the NH stock is bound to reflect the impact of the QOQ decline of -17.04%. One also needs to look at NantHealth assets, operating expenses and NantHealth free cash flow. The NantHealth profit and loss statement shows revenue of $21.76M for 2017 Q3. Revenue has decreased by -17.04% QoQ for NH stock.

View and download details of revenue and profits for NantHealth for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
NantHealth Revenues or Net Sales
Cost Of Goods Sold (COGS)11.47M16.67M19.02M19.83M17.23M22.24M13.03M10.86M12.09M
NantHealth Gross Profit
Research & Development Expense7.74M11.84M13.39M12.77M13.85M24.32M10.69M7.16M7.02M
Selling General & Admin Expense17.52M22.94M20.87M21.33M24.71M47.24M27.37M16.65M18.14M
Income Before Depreciation Depletion Amortization-14.98M-25.23M-30.79M-29.83M-30.44M-62.32M-31.65M-14.25M-22.86M
Depreciation Depletion Amortization1.05M1.81M1.81M1.82M1.81M1.81M1.81M--
Non Operating Income-2.88M-38.82M-4.25M-31.11M-2.94M-2.45M-2.57M-2.44M-
Interest Expense4.06M4.01M3.96M1.69M1.41M1.75M1.49M--
NantHealth Pretax Income
Provision for Income Taxes----4.46M--14.21M-4.39M--
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-23.02M-70.06M-41.12M-59.95M-36.87M-54.13M-33.14M-17.87M-22.95M
Extraordinary Items & Discontinued Operations-19.38M--------
NantHealth Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS115.92M121.76M121.62M121.24M121.25M104.07M---
Average Shares used to compute Basic EPS115.92M121.76M121.62M121.24M121.25M104.07M---
Income Before Nonrecurring Items-23.02M-70.06M-29.42M-26.1M-27.62M-60.21M---
Income from Nonrecurring Items---11.7M-33.85M-9.26M6.08M---
NantHealth Earnings Per Share Basic Net
NantHealth Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.20-0.58-0.24-0.21-0.22-0.59---
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on NantHealth stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the NantHealth revenue chart, as isn't the case with NantHealth indicates a sagging business. One needs to compare the QoQ topline or sales growth of NH stock with its peers like CPSI stock and NVTA stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-42.4M for NantHealth for 2017 Q3. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the NH income statement, one can check the NantHealth historical stock prices to check how the price has moved with time.

NantHealth Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield